COVAX facility

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instanceOf gptkb:healthcare_organization
gptkbp:addresses vaccine_hesitancy
gptkbp:aimsTo ensure equitable access to COVID-19 vaccines
increase vaccine production capacity
distribute 2 billion vaccine doses by the end of 2021
reduce the risk of COVID-19 variants
support health systems in countries
gptkbp:focusesOn low- and middle-income countries
gptkbp:hasCollaboratedWith gptkb:World_Bank
UNICEF
regional organizations
https://www.w3.org/2000/01/rdf-schema#label COVAX facility
gptkbp:isAimedAt achieving herd immunity
protecting vulnerable populations
reducing mortality from COVID-19
gptkbp:isChallengedBy supply chain issues
political barriers
logistical hurdles
vaccine nationalism
vaccine production delays
gptkbp:isCriticizedFor global health security
gptkbp:isEvaluatedBy external audits
gptkbp:isFacilitatedBy clinical trials for vaccines
vaccine distribution in over 140 countries
gptkbp:isFundedBy bilateral agreements
donor contributions
multilateral funding
gptkbp:isGovernedBy Steering_Committee
gptkbp:isInvolvedIn vaccine procurement
vaccine distribution logistics
gptkbp:isMonitoredBy independent experts
gptkbp:isPartOf global vaccination efforts
Access to COVID-19 Tools (ACT) Accelerator
global response to pandemics
gptkbp:isPromotedBy media campaigns
public health campaigns
social media initiatives
gptkbp:isRecognizedBy international health organizations
governments worldwide
gptkbp:isSupportedBy various governments
scientific community
private sector partners
healthcare_professionals
philanthropic organizations
gptkbp:launched 2020
gptkbp:ledTo gptkb:CEPI
gptkb:GAVI,_the_Vaccine_Alliance
WHO
gptkbp:operates international collaboration
gptkbp:provides technical assistance to countries
vaccines to participating countries
gptkbp:worksWith manufacturers of vaccines